SCHEMBL5465286

SCHEMBL5465286

CNC(C1CCN(c2c(F)cc3c(=O)[nH]c(=O)n(C4CC4)c3c2OC)C1)C(C)(C)C#N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.42
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
POLB P06746 1/20 0.36
PRKD3 O94806 1/20 0.36
ALOX15 P16050 1/20 0.36
OPRM1 P35372 1/20 0.36
CLK2 P49760 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CACNA1C Q13936 1/20 0.35
SCN5A Q14524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5466746 0.90 KCNH2 (0.47) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL5459406 0.90 KCNH2 (0.43) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5458113 0.88 KCNH2 (0.43) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL5455435 0.86 KCNH2 (0.43) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL5460769 0.85 KCNH2 (0.43) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL7099722 0.85 KCNH2 (0.48) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL6669083 0.85 KCNH2 (0.48) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL5466816 0.85 KCNH2 (0.40) KCNH2
SCHEMBL5802126 0.83 KCNH2 (0.36) KCNH2KDM4EALDH1A1HPGDPOLB
SCHEMBL5460712 0.82 KCNH2 (0.49) KCNH2KDM4EALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed
EP-1687296-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES Warner-Lambert Company LLC (US) 2006-08-09 EP disclosed
WO-2005049605-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191333-A1 Antibacterial agents MRPL21, RPN2, FBL KCNH2 2633/4885KDM4E 4500/4885ALDH1A1 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.